SCHEMBL24630673

SCHEMBL24630673

CC(C)(C)c1cc(Cn2c(C(C)(C)C)cc3ccc(C(C)(C)C)c(F)c32)c2cc(C(C)(C)C)n(COP(=O)(O)O)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21341470 0.74 HDAC10 (0.39) —
SCHEMBL21341405 0.72 — —
SCHEMBL24944145 0.70 EIF4A3 (0.33) —
SCHEMBL31265044 0.63 PGR (0.43) —
SCHEMBL21341402 0.61 CFTR (0.37) —
SCHEMBL21341404 0.60 KDM4E (0.30) —
SCHEMBL21341334 0.57 CCR9 (0.39) —
SCHEMBL31265066 0.55 HSD17B10 (0.40) —
SCHEMBL24943811 0.55 CCR9 (0.38) —
SCHEMBL21983448 0.55 CCR9 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220378743-A1 METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) 2022-12-01 — — US disclosed
Send feedback